MobiHealth News September 16, 2020

The 900-participant study uses learnings from Apple’s Tueo Health acquisition and could inform the development of a digital biomarker for asthma.

Apple and Anthem, along with the University of California, Irvine, and software company CareEvolution, have teamed up to launch a two-year, 900-participant study investigating how digital tools can help patients control their asthma and reduce hospital utilization.

“The Digital Asthma Study brings together Apple Watch’s innovative technology with an engaging app-based self-management experience to investigate how consumers can better manage and control a prevalent condition,” Myoung Cha, Apple’s head of Health Strategic Initiatives, said in a statement. “We hope this study can help the medical community produce new insights about asthma control and can identify effective digital tools that...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Apps, Digital Health, Insurance, Patient / Consumer, Payer, Provider, Technology, Wearables
Too much data? Wearables for senior care have value but providers must know how to parse their output, experts say
'From Interpretation to Action': Using CGM to Manage T2D
Roche develops continuous glucose monitor with predictive algorithms
Novosound locks down patent for wearable ultrasound imaging platform
Wearable Technology Transforms Clinical Trials with Continuous Remote Monitoring

Share This Article